Drug capsules for preventing and treating chronic atrophic gastritis

The technology for atrophic gastritis and capsules is applied in the field of pharmaceutical preparations, and can solve the problems of affecting the physical and chemical properties and curative effects of traditional Chinese medicine preparations, affecting the overall curative effect of traditional Chinese medicinal compositions, affecting the curative effects of traditional Chinese medicinal compositions, etc., so as to increase immunity of the body and relieve deliquescence. , the effect of improving compliance

Inactive Publication Date: 2017-05-10
刘志华
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Most of the raw materials used in the above Chinese medicine compositions have problems such as poor curative effect and slow effect to varying degrees, and some Chinese medicine raw materials do not have synergistic effects with other raw materials, which affects the overall curative effect of the Chinese medicine composition
Moreover, most of the existing traditional Chinese medicine compositions are directly pulverizing the raw materials used into medicine, without extracting and separating the active ingredients in the raw materials, not removing the non-effective ingredients, and having more impurities, which makes the prescription of the traditional Chinese medicine composition too large, which is not conducive to patients. Take, further affect the curative effect of Chinese medicine composition
In addition, the excipients in the existing traditional Chinese medicine preparations for the treatment of chronic gastritis are all conventional pharmaceutical excipients, and when the traditional Chinese medicine preparations enter the stomach to exert their curative effect, because the patient's stomach does not select the appropriate excipients according to the properties of the traditional Chinese medicine composition, thus It further affects the physical and chemical properties and curative effect of traditional Chinese medicine preparations, limiting its application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] Example 1. The drug capsule for preventing and treating chronic atrophic gastritis is made of main drug components and capsule auxiliary materials. Extract composition of ginger medicinal material.

[0041] Calculated on the basis of each thousand capsules, the dosage of each component of the drug capsule is: Codonopsis 110g, fried jujube kernel 90g, fried Atractylodes macrocephala 120g, Poria cocos 110g, roasted licorice 650g, yam 125g, curcuma 105g, Fa Pinellia 82g, Pao Ginger 70g.

[0042] The main ingredient is prepared by the following method:

[0043] Step 1: Grind fried jujube kernels and paojiang into fine powder, sieve, and set aside;

[0044] Step 2: Take Codonopsis pilosula, Poria cocos, roasted licorice, yam, zedoary, French pinellia, and stir-fried Atractylodes macrocephala, add 4-6 times the amount of water to soak for 1-1.5 hours, first fry on high heat and then turn to low heat and fry for 1-1.5 hours , decanting the medicinal juice for later use; ad...

Embodiment 2

[0066] Example 2. The drug capsule for preventing and treating chronic atrophic gastritis is made of main drug components and capsule auxiliary materials. Extract composition of ginger medicinal material.

[0067] Calculated on the basis of each thousand capsules, the dosage of each component of the drug capsule is: Codonopsis 130g, fried jujube kernel 102g, fried Atractylodes macrocephala 135g, Poria cocos 120g, roasted licorice 73g, yam 135g, curcuma 123g, Fabanxia 87g, Pao Ginger 73g.

[0068] The main ingredient is prepared by the following method:

[0069] Step 1: Grind fried jujube kernels and paojiang into fine powder, sieve, and set aside;

[0070] Step 2: Take Codonopsis pilosula, Poria cocos, roasted licorice, yam, zedoary, French pinellia, and stir-fried Atractylodes macrocephala, add 4-6 times the amount of water to soak for 1-1.5 hours, first fry on high heat and then turn to low heat and fry for 1-1.5 hours , decanting the medicinal juice for later use; addin...

Embodiment 3

[0092] Example 3. The drug capsule for preventing and treating chronic atrophic gastritis is made of main drug components and capsule auxiliary materials. Extract composition of ginger medicinal material.

[0093] Calculated on the basis of each thousand capsules, the dosage of each component of the drug capsule is: Codonopsis 100g, fried jujube kernel 82g, fried Atractylodes macrocephala 110g, Poria cocos 100g, roasted licorice 65g, yam 120g, curcuma 105g, Fa Pinellia 80g, Pao Ginger 65g.

[0094] The main ingredient is prepared by the following method:

[0095] Step 1: Grind fried jujube kernels and paojiang into fine powder, sieve, and set aside;

[0096] Step 2: Take Codonopsis pilosula, Poria cocos, roasted licorice, Chinese yam, curcuma, French pinellia, and stir-fry Atractylodes macrocephala, add 4-6 times the amount of water and soak for 1 hour, first fry on high heat, then turn to low heat and fry for 1 hour, decant the medicine juice for later use; for the second...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses drug capsules for preventing and treating chronic atrophic gastritis and belongs to the technical field of drug preparations. The drug capsules are made with a main drug component and a capsule auxiliary material; the main drug component comprises tangshen root, roasted seed of common jujube, roasted rhizome of largehead atractylodes, Poria, prepared licorice root, rhizome of common yam, turmeric rhizome, prepared rhizome of ternate pinellia, and baked ginger; the capsule auxiliary material includes a binder, a filling agent, a cracking agent, an adsorbent, and a lubricant. The drug capsules are capable of significantly decreasing the progress and development of chronic atrophic gastritis, decreasing the complications such as gastric cancer, and maximally increasing the living quality of a patient.

Description

technical field [0001] The invention belongs to the field of pharmaceutical preparations, in particular to pharmaceutical capsules for preventing and treating chronic atrophic gastritis. Background technique [0002] Chronic gastritis refers to various chronic gastric mucosal inflammatory lesions caused by different etiologies, and is a common disease; according to histopathological changes and the distribution of lesions in the stomach, combined with possible etiologies, chronic gastritis can be divided into non-atrophic and atrophic There are three kinds of sex and special types; patients with chronic gastritis are asymptomatic in the early stage, and mainly manifest as upper abdominal pain or discomfort, upper abdominal distension, early satiety, nausea and other indigestion symptoms. [0003] Chronic atrophic gastritis is a common digestive system disease that seriously threatens the health of the masses. According to the 2016 China Stomach Disease Survey Report, among ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9068A61K9/48A61P1/04A61P7/06A61P35/00A61P37/04A61P25/20
CPCA61K36/344A61K9/4866A61K36/076A61K36/284A61K36/484A61K36/725A61K36/8888A61K36/8945A61K36/9066A61K36/9068A61K2236/331A61K2236/39A61K2236/51A61K2300/00
Inventor 刘志华
Owner 刘志华
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products